Assessing allocation bias in stratified clinical trials with multi-component endpoints evaluated using the stratified Wei-Lachin test.
<h4>Background</h4>A common issue in rare disease stratified clinical trials with multi-component endpoints is allocation bias, as they frequently lack blinding. Allocation bias arises when future treatment allocations can be predicted from prior ones, potentially leading to patients with specific c...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Public Library of Science (PLoS)
2026-01-01
|
| Reeks: | PLoS ONE |
| Online toegang: | https://doi.org/10.1371/journal.pone.0341039 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|